OTC : ERFSF

Eurofins Scientific SE

$78.13 USD

-$0.6 (-0.76%)

Volume
790
Average Volume
3.96K
Market Capitalization
$13.52B
P/E Ratio
28.09
Dividend Yield
1.03%
Price Target
Year High
$86.20
Year Low
$64.95
Day High
—
Day Low
—
Payout Ratio
$0.12
Current Ratio
$1.09
Company Overview

OTC

Gilles G. Martin

Medical - Diagnostics & Research

Healthcare

ERFSF

65694

LU

USD

https://www.eurofins.com

352 26 18 53 20

N/A

N/A

Liquidity Metrics

1.53

1.09

1.03

0.33

0.12

Sales & Valuation

$7.29B

1.65

3.54

29.84

2.24

Profitability

$2.54

$474.82M

6.51%

8.97%

11.62%

4.32%

P/E Metrics

28.09

1.71

1.71

Analyst Price Target & Rating

Neutral

3/5

4 Analysts

%

Financial Health Scores

3.21

5/9

$222.92M

$10.98B

$7.4B

$1.71B

Key Metrics (TTM)

$16.94B

2.32

15.37

1.09

11.62%

8.88%

3.71%

3.28%

$34.19

45 days

Company Executives
Name Title
Timothy S. Oostdyk Executive Vice President of BioPharma, Genomics & Agrosciences Services North America
Bernard Wang Head of Investor Relations
David W. Bryant Senior Vice President of Strategic Business Development North America
Joachim Reichelt Senior Vice President of Food & Feed Testing Europe
Laurent Lebras Group Administration & Chief Financial Officer
Valerie Hanote Executive Director
Yvoine Remy Senior Vice President of Environment Testing Europe
Gilles G. Martin Chairman of the Board & Chief Executive Officer
Francois Vigneau Senior Vice President of Food & Feed Testing - Western Europe
Gabriel Julia Senior Vice President of Clinical Diagnostics Europe
Poll Results

No votes yet today — be the first to share your view!

About Eurofins Scientific SE (OTC:ERFSF) Stock

Eurofins Scientific SE, along with its affiliated companies, delivers a broad spectrum of analytical testing and laboratory solutions globally. The firm utilizes an extensive repertoire of approximately 200,000 analytical techniques, designed to assess various product attributes such as safety, identification, makeup, genuineness, source, trackability, and cleanliness. Its offerings span numerous sectors. These include agro-science, encompassing biological evaluations, consumer, human, and environmental safety assessments, product chemical analysis, regulatory guidance, and seed services. The company also handles general agro testing. Its assurance division provides product inspections, audits, certifications, training, and advisory services for items across food, consumer goods, healthcar ... e, and cosmetics industries. Other specialized areas are biopharma and clinical diagnostics. Furthermore, Eurofins conducts comprehensive consumer product testing, covering compliance, audits, examinations, certifications, inspections, training programs, and digital media and cybersecurity solutions for a diverse range of sectors. It also specializes in cosmetics and personal care product analysis, and environmental testing for substances like water, air, soil, waste, and other materials. Food and feed testing is another key segment, addressing concerns such as allergens, GMOs, grain quality, meat composition, nanomaterials, pesticides, and residual DNA. The company's extensive food-related portfolio also includes audit and certification services, authenticity verification, carbohydrate analysis, consulting, detection of dioxins and persistent organic pollutants (POPs), food irradiation checks, labeling compliance, legal guidance, heavy metal screening, identity preservation, mealtime analysis, molecular and microbiology testing, mycotoxin detection, nutritional profiling, organic contaminant analysis, packaging and migration studies, radioactivity testing, rapid testing methods, sensory and consumer research, various training initiatives, veterinary drug residue screening, and vitamin content analysis. Beyond these, Eurofins offers expertise in forensic science, genomics, maritime applications, materials and engineering, REACH compliance, and advanced technologies. The company maintains a significant global presence, operating roughly 900 laboratories across 54 nations. Established in 1987, its main office is situated in Luxembourg City, Luxembourg.

Eurofins Scientific: Director/PDMR Shareholding

2026-07-21 11:41:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the p.

Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026

2026-07-20 11:45:00

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 13th July to 17th July 2026   Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07/2026 FR0014000MR3 15 000 69.1984 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07.

Eurofins Scient (OTCMKTS:ERFSF) Shares Up 5.5% – Should You Buy?

2026-07-19 04:01:57

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) was up 5.5% on Friday. The company traded as high as $82.1280 and last traded at $81.9360. Approximately 271 shares changed hands during trading, a decline of 94% from the average session volume of 4,912 shares. The stock had previously closed at $77.67. Eurofins Scient Stock Up

Eurofins Scientific: Director/PDMR Shareholding

2026-07-16 11:05:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the per.

Eurofins Scientific: Director/PDMR Shareholding

2026-07-08 13:00:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF): Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details.

Eurofins Scientific: Director/PDMR Shareholding

2026-06-25 08:46:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the p.

Eurofins Scientific: Director/PDMR Shareholding

2026-06-22 08:47:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the p.

CORRECTING and REPLACING: Eurofins Scientific: Director/PDMR Shareholding

2026-06-17 13:34:00

LUXEMBOURG--(BUSINESS WIRE)--This replaces the announcement made on 16 June 2026 due to the following correction: updated number of stock options exercised. The updated release reads: EUROFINS SCIENTIFIC: DIRECTOR/PDMR SHAREHOLDING Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European.

Frequently Asked Questions

What is the current Eurofins Scientific SE (ERFSF) stock price?

Eurofins Scientific SE(OTC:ERFSF) stock price is $78.13 in the last trading session. During the trading session, ERFSF stock reached the peak price of $86.2 while $64.95 was the lowest point it dropped to. The percentage change in ERFSF stock occurred in the recent session was --0.76% while the dollar amount for the price change in ERFSF stock was -$0.6.

ERFSF's industry and sector of operation?

The OTC listed ERFSF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of ERFSF?

Timothy S. Oostdyk | Executive Vice President of BioPharma, Genomics & Agrosciences Services North America
Bernard Wang | Head of Investor Relations
David W. Bryant | Senior Vice President of Strategic Business Development North America
Joachim Reichelt | Senior Vice President of Food & Feed Testing Europe
Laurent Lebras | Group Administration & Chief Financial Officer

How many employees does ERFSF have?

Number of ERFSF employees currently stands at 65694. ERFSF operates from 23 Val Fleuri, Luxembourg City, LU 1526, LU.

Link for ERFSF official website?

Official Website of ERFSF is: https://www.eurofins.com

How do I contact ERFSF?

ERFSF could be contacted at phone #352 26 18 53 20 and can also be accessed through its website. ERFSF operates from 23 Val Fleuri, Luxembourg City, LU 1526, LU.

How many shares of ERFSF are traded daily?

The average number of ERFSF shares traded daily for last 3 months was 3.96K.

What is the market cap of ERFSF currently?

The market value of ERFSF currently stands at $13.52B with its latest stock price at $78.13